Dominic Boardman is a Senior Scientist in CAR T cell Therapeutics at AstraZeneca, where they apply their expertise in optimizing Tregs for therapeutic use. They previously served as a Postdoctoral Fellow at BC Children's Hospital Research Institute from 2017 to 2023 and completed a Ph.D. in Transplant Immunology at King's College London in 2017. Dominic earned their Master’s degrees with distinction in Biomedical and Translational Sciences and Immunology, both from King's College London, following a Bachelor's degree in Biochemistry from Imperial College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices